Rivia
Know better. Act better.
Know better. Act better.
Rivia is a startup specializing in AI-driven analytics and data infrastructure for more successful biopharma clinical trials. Their slogan "Integrated Clinical Trial Intelligence" encapsulates their focus on addressing inefficiencies and failures in clinical trials faced by biopharmas. Founded in 2022 and headquartered in Switzerland, Rivia aims to offer a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. The company's vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully. Rivia recently received a significant €3.00M Seed Round investment on 12 June 2024 from prominent investors including Speedinvest, Nina Ventures, and Amino Collective. This backing underscores investor confidence in Rivia's potential to drive innovation and efficiency in the biopharma industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €3.00M | 3 |
|
12 Jun 2024 |
We care about your data, and we'd love to use cookies make your experience better.
